Abstract:The tumor microenvironment (TME) is crucial in cancer progression and immunotherapy response. Optical imaging techniques provide a noninvasive, real time method to analyze immune cells in the TME, helping predict and monitor immunotherapy outcomes. This review highlights advancements in optical imaging for TME immunotherapy and its potential in clinical trials and personalized cancer treatment. Background The tumor microenvironment (TME) plays a critical role in cancer progression and response to immunotherapy. Immunotherapy targeting the immune system has emerged as a promising treatment modality, but challenges in understanding the TME limit its efficacy. Optical imaging strategies offer noninvasive, real‐time insights into the interactions between immune cells and the TME. Objective This review assesses the progress of optical imaging technologies in monitoring immunotherapy within the TME and explores their potential applications in clinical trials and personalized cancer treatment. Methods This is a comprehensive literature review based on the advances in optical imaging modalities including fluorescence imaging (FLI), bioluminescence imaging (BLI), and photoacoustic imaging (PAI). These modalities were analyzed for their capacity to provide high‐resolution, real‐time imaging of immune cell dynamics, tumor vasculature, and other critical components of the TME. Results Optical imaging techniques have shown significant potential in tracking immune cell infiltration, assessing immune checkpoint inhibitors, and visualizing drug delivery within the TME. Technologies like FLI and BLI are pivotal in tracking immune responses in preclinical models, while PAI provides functional imaging with deeper tissue penetration. The integration of these modalities with immunotherapy holds promise for improving treatment monitoring and outcomes. Conclusion Optical imaging is a powerful tool for understanding the complexities of the TME and optimizing immunotherapy. Further advancements in imaging technologies, combined with nanomaterial‐based approaches, could pave the way for enhanced diagnostic accuracy and therapeutic efficacy in cancer treatment.

Monitoring Immunotherapy With Optical Molecular Imaging

Molecular Imaging for Cancer Immunotherapy: Seeing is Believing

Innovative optical imaging strategies for monitoring immunotherapy in the tumor microenvironments

Positron Emission Tomography Molecular Imaging to Monitor Anti-Tumor Systemic Response for Immune Checkpoint Inhibitor Therapy

Emerging Biomaterials Imaging Antitumor Immune Response

Imaging strategies for monitoring the immune response.

Outcome Prediction and Evaluation by Imaging the Key Elements of Therapeutic Responses to Cancer Immunotherapies Using PET

Molecular MRI-Based Monitoring of Cancer Immunotherapy Treatment Response

Progress of Molecular Imaging-guided Tumor Immunotherapy

Molecular imaging of cell-based cancer immunotherapy.

Advances in molecular imaging of immune checkpoint targets in malignancies: current and future prospect

Molecular imaging to support cancer immunotherapy

Application of Molecular Imaging in Immune Checkpoints Therapy: from Response Assessment to Prognosis Prediction.

Illuminating immunotherapy response via precision T cell-targeted PET imaging

Imaging Beyond Seeing: Early Prognosis of Cancer Treatment.

Potential non-invasive biomarkers in tumor immune checkpoint inhibitor therapy: response and prognosis prediction

In Vivo Clinical Molecular Imaging of T Cell Activity.

Progresses in biomarkers for cancer immunotherapy

Intravital imaging of the functions of immune cells in the tumor microenvironment during immunotherapy

Therapeutic targets and biomarkers of tumor immunotherapy: response versus non-response

Immunotherapy and the role of imaging